NCT00499408View on ClinicalTrials.gov

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

Vitamin D

Patients will receive oral supplementation of 2,000 IU per day of vitamin D (cholecalciferol)

DIETARY_SUPPLEMENT

soy

Patients will receive oral supplementation of soy (160 mg per day soy isoflavones).

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00499408 - Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter